Vontobel Holding’s Royalty Pharma RPRX Stock Holding History

Vontobel Holding’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	4,913 +442	+10%	+$23K	﹤0.01%	1258
2026 Q1	$214K	Buy	+4,471	New	+$196K	﹤0.01%	1092
2025 Q3	–	Sell	-6,716	Closed	-$242K	–	1419
2025 Q2	$242K	Sell	6,716 -788	-11%	-$26.1K	﹤0.01%	1117
2025 Q1	$234K	Sell	7,504 -1,494	-17%	-$47.4K	﹤0.01%	970
2024 Q4	$230K	Buy	+8,998	New	+$239K	﹤0.01%	974
2021 Q4	–	Sell	-6,105	Closed	-$221K	–	1189
2021 Q3	$221K	Buy	6,105 +481	+9%	+$18.7K	﹤0.01%	1014
2021 Q2	$231K	Buy	+5,624	New	+$239K	﹤0.01%	1001

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vontobel Holding's RPRX Position: Q2 2026 in Review

Vontobel Holding increased its Royalty Pharma (RPRX) stake by 9.9% in Q2 2026, buying an estimated $23K and bringing the position to 4,913 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

Vontobel Holding first reported a position in RPRX in Q2 2021 and has held it in 7 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Vontobel Holding held 4,913 shares of Royalty Pharma worth $275K as of Q2 2026.
Vontobel Holding bought 442 Royalty Pharma shares in Q2 2026, an estimated $23K.
Royalty Pharma made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1258 holding.
Vontobel Holding first reported a position in Royalty Pharma in Q2 2021 and has held it in 7 quarters since.
641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.